156 related articles for article (PubMed ID: 16492932)
1. Plasma C-reactive protein and risk of cancer: a prospective study from Greece.
Trichopoulos D; Psaltopoulou T; Orfanos P; Trichopoulou A; Boffetta P
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):381-4. PubMed ID: 16492932
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein and the risk of cancer: a mendelian randomization study.
Allin KH; Nordestgaard BG; Zacho J; Tybjaerg-Hansen A; Bojesen SE
J Natl Cancer Inst; 2010 Feb; 102(3):202-6. PubMed ID: 20056955
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
Siemes C; Visser LE; Coebergh JW; Splinter TA; Witteman JC; Uitterlinden AG; Hofman A; Pols HA; Stricker BH
J Clin Oncol; 2006 Nov; 24(33):5216-22. PubMed ID: 17114654
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein concentrations and subsequent ovarian cancer risk.
McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
[TBL] [Abstract][Full Text] [Related]
5. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):690-5. PubMed ID: 16614110
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein and risk of breast cancer.
Zhang SM; Lin J; Cook NR; Lee IM; Manson JE; Buring JE; Ridker PM
J Natl Cancer Inst; 2007 Jun; 99(11):890-4. PubMed ID: 17551149
[TBL] [Abstract][Full Text] [Related]
7. Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population.
Marott SC; Nordestgaard BG; Zacho J; Friberg J; Jensen GB; Tybjaerg-Hansen A; Benn M
J Am Coll Cardiol; 2010 Aug; 56(10):789-95. PubMed ID: 20797493
[TBL] [Abstract][Full Text] [Related]
8. [C-reactive protein, risk of and survival after cancer--secondary publication].
Allin KH; Bojesen SE; Nordestgaard BG
Ugeskr Laeger; 2009 Nov; 171(48):3510-3. PubMed ID: 19953727
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of the acute-phase serum amyloid are associated with heightened lung cancer risk.
Cremona M; Calabrò E; Randi G; De Bortoli M; Mondellini P; Verri C; Sozzi G; Pierotti MA; La Vecchia C; Pastorino U; Bongarzone I
Cancer; 2010 Mar; 116(5):1326-35. PubMed ID: 20087959
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of serum C-reactive protein and colorectal cancer risk in men.
Gunter MJ; Stolzenberg-Solomon R; Cross AJ; Leitzmann MF; Weinstein S; Wood RJ; Virtamo J; Taylor PR; Albanes D; Sinha R
Cancer Res; 2006 Feb; 66(4):2483-7. PubMed ID: 16489056
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein and colorectal adenoma in the CLUE II cohort.
Tsilidis KK; Erlinger TP; Rifai N; Hoffman S; Hoffman-Bolton J; Helzlsouer KJ; Platz EA
Cancer Causes Control; 2008 Aug; 19(6):559-67. PubMed ID: 18214695
[TBL] [Abstract][Full Text] [Related]
13. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
[TBL] [Abstract][Full Text] [Related]
14. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer.
Allin KH; Nordestgaard BG
Crit Rev Clin Lab Sci; 2011; 48(4):155-70. PubMed ID: 22035340
[TBL] [Abstract][Full Text] [Related]
15. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer.
Allin KH; Bojesen SE; Nordestgaard BG
J Clin Oncol; 2009 May; 27(13):2217-24. PubMed ID: 19289618
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory markers in late-life depression: results from a population-based study.
Bremmer MA; Beekman AT; Deeg DJ; Penninx BW; Dik MG; Hack CE; Hoogendijk WJ
J Affect Disord; 2008 Mar; 106(3):249-55. PubMed ID: 17716746
[TBL] [Abstract][Full Text] [Related]
17. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
Youssef MY; Mojiminiyi OA; Abdella NA
Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
[TBL] [Abstract][Full Text] [Related]
18. Is C-reactive protein a prognostic factor of colorectal cancer?
Shiu YC; Lin JK; Huang CJ; Jiang JK; Wang LW; Huang HC; Yang SH
Dis Colon Rectum; 2008 Apr; 51(4):443-9. PubMed ID: 18172726
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
20. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study.
Bos MJ; Schipper CM; Koudstaal PJ; Witteman JC; Hofman A; Breteler MM
Circulation; 2006 Oct; 114(15):1591-8. PubMed ID: 17015791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
